Dupilumab Improves Health-Related Quality of Life and a Range of Symptoms in Patients With Eosinophilic Esophagitis
Jonathan M. Spergel(Children's Hospital of Philadelphia), Eilish McCann(Northwestern University), Sarette T. Tilton(Sanofi (United States)), Lila Glotfelty(Icahn School of Medicine at Mount Sinai), Arsalan Shabbir(Northwestern University), Xian Sun(Regeneron (United States)), Evan S. Dellon(University of North Carolina at Chapel Hill), Mirna Chehade(New York Proton Center), Albert J. Bredenoord(Universität Hamburg)
Cited by 12
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
Burden of Gastrointestinal Disease in the United States: 2012 Update
|Gastroenterology|2012|2k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States
|Gastroenterology|2015|996